SCHEMBL25072073

SCHEMBL25072073

COC1CC(NC(=O)OCc2ccccc2)CN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.48
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
CTSL P07711 1/20 0.45
CTSB P07858 1/20 0.45
CTSK P43235 1/20 0.45
PDE4B Q07343 1/20 0.45
L3MBTL1 Q9Y468 2/20 0.44
KMT2A Q03164 1/20 0.44
TSHR P16473 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
ACHE P22303 2/20 0.44
ABCB1 P08183 1/20 0.44
USP30 Q70CQ3 1/20 0.43
CPB1 P15086 1/20 0.43
DPP4 P27487 3/20 0.43
DPP7 Q9UHL4 3/20 0.43
KCNH2 Q12809 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20498564 0.92 PDE4B (0.53) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL4131437 0.92 PDE4B (0.53) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL376879 0.92 PDE4B (0.53) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL29232309 0.89 ALDH1A1 (0.53) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL13630910 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL8097829 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL30736145 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL8097832 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL25438608 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB
SCHEMBL7948452 0.88 HSD11B1 (0.48) HSD11B1ALDH1A1GAACTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12071425-B2 Phenoxy-pyridyl-pyrimidine compounds and methods of use GENENTECH, INC. (US) 2024-08-27 US disclosed
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2023-02-23 US disclosed
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE GENENTECH INC (US) 2023-02-23 US disclosed
CN-112739420-A Phenoxy-pyridyl-pyrimidine compounds and methods of use 基因泰克公司 2021-04-30 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230057166-A1 PHENOXY-PYRIDYL-PYRIMIDINE COMPOUNDS AND METHODS OF USE XBP1, ERN1, ESR2 HSD11B1 519/4885ALDH1A1 2362/4885GAA 1533/4885
US-12071425-B2 Phenoxy-pyridyl-pyrimidine compounds and methods of use XBP1, ERN1, ESR2 HSD11B1 519/4885ALDH1A1 2362/4885GAA 1533/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.